Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3343077 | Best Practice & Research Clinical Rheumatology | 2014 | 14 Pages |
Abstract
This manuscript focuses on the pharmacologic treatment of psoriatic arthritis and axial spondyloarthritis – including ankylosing spondylitis – using traditional biologic and non-biologic disease-modifying antirheumatic drugs. Early treatment of psoriatic arthritis and axial spondyloarthritis/ankylosing spondylitis as well as the treat-to-target concept receive particular attention. This review also surveys recent national and international guidelines for the treatment of both psoriatic arthritis and couches practice recommendations for axial spondyloarthritis/ankylosing spondylitis within the context of various international guidelines.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Enrique Roberto Soriano, Maria Laura Acosta-Felquer, Phat Luong, Liron Caplan,